04 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viking-therapeutics-announces-positive-52-week-histologic-data-from-phase-2b-voyage-study-of-vk2809-in-patients-with-biopsy-confirmed-non-alcoholic-steatohepatitis-nash-302162714.html
LOOKING FOR A SUPPLIER?